Hydroxychloroquine calms lupus by interfering with the immune system at a cellular level, reducing the overactive immune response that drives the disease. It’s one of the few medications recommended for virtually all lupus patients, and its benefits extend well beyond controlling symptoms. Staying on it long-term is associated with a 65% lower risk of death compared to people who stop taking it.
What Happens Inside Your Cells
Hydroxychloroquine is a weak base, meaning it naturally drifts toward acidic environments inside your cells. It concentrates in lysosomes and endosomes, tiny compartments that act like recycling centers where immune cells break down proteins and prepare them for inspection. Once inside, the drug gets trapped and raises the pH of these compartments from about 4 to 6. That shift sounds small, but it’s enough to shut down the enzymes that do the breaking-down work.
This matters because your immune system relies on that process to identify threats. Macrophages and dendritic cells (key players in immune surveillance) chop up proteins and display fragments on their surface using a structure called MHC class II. Other immune cells read those fragments to decide whether to mount an attack. When hydroxychloroquine disrupts this step, fewer protein fragments get displayed, and the downstream immune response weakens. In lupus, where the immune system mistakenly attacks the body’s own tissues, dialing down that signaling loop is exactly what’s needed.
How It Reduces Flares
The clinical payoff of this immune suppression is fewer and less severe flares. A large study from the Systemic Lupus International Collaborating Clinics found that patients who reduced their dose had a 20% higher rate of flares compared to those who stayed on a full dose. Patients who stopped entirely had a 56% higher flare rate. These numbers held up even after adjusting for disease severity, meaning the drug itself was responsible for the difference, not just the fact that healthier patients were more likely to keep taking it.
Kidney Protection
Lupus nephritis, where the immune system attacks the kidneys, is one of the most serious complications of the disease. Hydroxychloroquine significantly slows kidney damage. In a study tracking over 200 lupus nephritis patients across nearly three decades, every five years of hydroxychloroquine use was linked to a 58% lower risk of sustained kidney function decline. For patients who already had moderate-to-severe kidney disease at the time of their lupus nephritis diagnosis, the protection was even more dramatic: a 90% lower risk of further decline.
The numbers on kidney filtration rate tell the same story from a different angle. Patients taking hydroxychloroquine lost kidney function at a rate of about 0.9 units per year, compared to 2.7 units per year for those not on the drug. That threefold difference compounds over time and can mean the difference between stable kidney function and dialysis.
Cholesterol and Heart Health
People with lupus face elevated cardiovascular risk due to chronic inflammation, steroid use, and the disease itself. Hydroxychloroquine has a surprisingly strong effect on blood lipids. Compared to placebo, it reduces total cholesterol by about 10%, LDL (“bad”) cholesterol by nearly 13%, and triglycerides by almost 28%. It also shifts the makeup of HDL cholesterol in a favorable direction, increasing the concentration of large HDL particles (the protective kind) by 17% while reducing small HDL particles by 20%.
These aren’t the kinds of changes you’d get from a dedicated cholesterol drug, but they’re meaningful when stacked on top of the drug’s other benefits, especially for patients already managing multiple risk factors.
Safety During Pregnancy
Hydroxychloroquine is one of the few lupus medications considered safe to continue during pregnancy, and stopping it can be risky. A meta-analysis pooling data from 668 pregnancies found that women who took hydroxychloroquine throughout pregnancy had roughly half the odds of experiencing high disease activity compared to those who didn’t (a 47% reduction). Among women whose lupus was well-controlled early in pregnancy, staying on the drug also cut the odds of preterm delivery by about 45%.
The drug did not appear to affect the risk of fetal loss or preeclampsia in the overall study population. But the clear reduction in flares during pregnancy is significant on its own, since flares themselves can trigger complications for both mother and baby.
How Long It Takes to Work
Hydroxychloroquine is not a fast-acting drug. Most people begin to notice improvement within one to three months, with benefits continuing to build for up to a year. This slow onset is a direct consequence of how the drug works: it gradually shifts the immune system’s baseline activity rather than suppressing a single inflammatory signal. Because of this, it’s important to keep taking it consistently even when you feel well. The flare data makes this especially clear, since stopping the drug, even after years of stability, raises the risk of a flare within months.
Dosing and Eye Safety
The main long-term risk of hydroxychloroquine is retinal toxicity, a form of damage to the back of the eye that can affect vision. The FDA recommends keeping the daily dose below 5 mg per kilogram of actual body weight to minimize this risk. For a person weighing 70 kg (about 154 pounds), that’s a maximum of 350 mg per day.
At proper doses, the risk of retinal damage stays below 1% within the first five years and under 2% even after ten years. After 20 years of continuous use, the incremental risk in any given year remains below 5%. Other factors that raise the risk include kidney impairment (which slows the drug’s clearance from the body), concurrent eye conditions, and certain other medications. The American Academy of Ophthalmology recommends baseline eye screening when starting the drug, followed by annual screening after five years of use, though your eye doctor may adjust that timeline based on your individual risk.
Why It’s Considered a Cornerstone Treatment
Few medications for lupus touch as many aspects of the disease as hydroxychloroquine does. It reduces flares, protects the kidneys, improves cholesterol, lowers mortality, and is safe enough to use during pregnancy. Current users have a 65% lower risk of death from any cause compared to people who previously took the drug but stopped. That survival benefit, combined with its relatively mild side effect profile, is why most lupus guidelines recommend that every patient with the disease take it unless there’s a specific reason not to.